5, 6-Diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors

Journal of Medicinal Chemistry

Volumn 44, Issue 24, 2001, Pages 4292-4295

  Giovannoni, M P ^a   Dal Piaz, V ^a   Kwon, B M ^b   Kim, M K ^b   Kim, Y K ^b   Toma, L ^c   Barlocco, D ^d   Bernini, F ^e   Canavesi, M ^e  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DIPHENYLPYRIDAZINE DERIVATIVE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; LIVER MICROSOME; MACROPHAGE; MOLECULAR MODEL; NONHUMAN;

ANIMALS; CELL-FREE SYSTEM; ENZYME INHIBITORS; MACROPHAGES; MICE; MICROSOMES, LIVER; MODELS, MOLECULAR; PYRIDAZINES; RATS; STEROL O-ACYLTRANSFERASE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035935748     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010807h     Document Type: Article

References (26)

1. Coronary atherosclerosis: A multifactorial desease
2. Role of acyl-CoA: Cholesterol acyltransferase in cellular cholesterol metabolism
3. CL 277,082: A novel inhibitors of ACAT-cathalized cholesterol esterification and cholesterol absorption
4. Rat liver acyl-coenzyme A: Cholesterol acyltransferase: Its regulation in vivo and some of its properties in vitro
5. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
6. Regulation of ACAT activity by a cholesterol substrate pool during the progression and regression phases of atherosclerosis: Implications for drug discovery
7. ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanisms
8. ACAT inhibitors: Evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents
9. Inhibitors of acyl-coA: Cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents
10. Inhibitors of acyl-CoA: Cholesterol O-acyltransferase. 2. Identification and structure-acrivity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N′-arylureas
11. Acyl-CoA cholesterol O-acyltransferase (ACAT) inhibitors. 1.2-(alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT
12. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitors (RP 73163) in animals fed diets low in cholesterol
13. GERI-BP001 compounds, new inhibitors of acyl-CoA:cholesterol acyltransferase from Aspergillus fumigatus F37 I. Production, isolation and physicochemical and biological properties
14. Advances in chemistry of pyridazines
15. Recent advances in the chemistry of pyridazines
16. Pyridazines. Part II. The action of grignard reagents on 6-aryl-2,3,4,5-tetrahydro-and -2,3-dihydropyridazin-3-ones
17. Uber glucoside von 3-mercaptopyridazinen/thiopyridazinen-(3)
18. Selective inhibition of acyl coenzyme A: Cholesterol acyltransferase by compound 58-035
19. In vitro model system: Cell cultures used in lipid and lipoprotein research
20. A study of dust toxicity. Using a quantitative tissue culture technique
21. Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A: Cholesterol acyltransferase
22. ACAT-2, a second mammalian acyl-CoA: Cholesterol acyltransferase
23. Disruption of the acyl-CoA: Cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals
24. AM1: A new general purpose quantum mechanical molecular model
25. Action of phenylmagnesium bromide on 4,5,6-trisubstituted pyridazin-3(2H)-ones